AAO Digital GUIDELINES Apps (free trial)

Age-Related Macular Degeneration

AAO GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/557417

Contents of this Issue

Navigation

Page 9 of 15

8 Management Î Vision rehabilitation restores functional ability and patients with reduced visual function should be referred for vision rehabilitation and social service. (III, G, S) Î Special optical or electronic magnifying lenses, bright lights, and electronic reading aids may help patients to read more effectively, but not as well as they did before the onset of AMD. (III, In, D) • An Implantable Miniature Telescope ™ (IMT) is an FDA-approved device that may be effective for screened, phakic, motivated patients with end-stage AMD, and it appears to be cost-effective. Î Patients with Charles Bonnet syndrome and their family members should be informed that visual symptoms are not unusual and do not represent a sign of psychosis or mental deterioration. (III, G, S) Î The ophthalmologist may inquire about symptoms of clinical depression and, when appropriate, suggest that the patient seek professional advice, as depression may exacerbate the effects of AMD. (III, G, S)

Articles in this issue

Archives of this issue

view archives of AAO Digital GUIDELINES Apps (free trial) - Age-Related Macular Degeneration